Accessibility Menu

Carl Zeiss Meditec Ag(FRA) AFX

Market Cap€2.80BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2000)+71%
5 Year-83%
1 Year-25%
1 Month+5%
€32.12
+0.38%
+0.12Today
Carl Zeiss Meditec Ag last closing stock price
MetricPriceDate
Last closeEUR 32.142026-08-31
Carl Zeiss Meditec Ag stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-0.5%EUR 32.302026-08-24
1 month+5.38%EUR 30.502026-07-31
3 month+23.14%EUR 26.102026-06-02
Year to date-19.65%EUR 40.002025-12-30
1 year-25.43%EUR 43.102025-08-29
3 year-64.88%EUR 91.522023-09-01
5 year-83.09%EUR 190.052021-09-01
Since inception+71.15%EUR 18.702000-03-22

Carl Zeiss Meditec Ag Financials at a Glance

Market Cap

€2.80BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

N/A

Net Income (TTM)

N/A

EPS (TTM)

€1.08

P/E Ratio

29.53

Dividend

€0.55

Beta (Volatility)

-0.08 (Low)

Price

€32.12

Volume

350

Open

€31.92

Previous Close

€32.12

Daily Range

€31.82 - €32.12

52-Week Range

€22.68 - €48.08

Estimated Earnings Date

N/A

AFX News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Carl Zeiss Meditec Ag

Carl Zeiss Meditec AG engages in the development, manufacture and marketing of medical devices. It operates through the Ophthalmic Devices and Microsurgery business segments. The Ophthalmic Devices segment includes intraocular lenses, surgical visualization solutions and medical laser and diagnostic systems. The Microsurgery segment offers surgical microscopes and visualization solutions for neuro, ear, nose, and throat surgery, as well as the activities in the field of intraoperative radiotherapy. The company was founded on July 2002 and is headquartered in Jena, Germany.

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

5,784

CEO

Maximilian Foerst

Website

www.zeiss.de

AFX Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

4.54%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

3.39%

Dividend Yield

1.72%

Payout Ratio

N/A

Stock Overview

Market Cap

€2.80BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

87.54M

Volume

350

Avg. Volume

1.07K

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Carl Zeiss Meditec Ag Performance Analysis

Carl Zeiss Meditec Ag annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-09-30EUR 1,902,836,00015.5%
20232023-09-30EUR 2,089,300,0009.8%
20242024-09-30EUR 2,066,127,000-1.1%
20252025-09-30EUR 2,227,645,0007.8%
Carl Zeiss Meditec Ag annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-09-30EUR 3.2924.4%
20232023-09-30EUR 3.25-1.2%
20242024-09-30EUR 2.01-38.0%
20252025-09-30EUR 1.61-19.8%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
CurrentYOY CHG

Revenue

N/A

N/A

Gross Profit

N/A

N/A

Gross Margin

N/A

N/A

Market Cap

€2.80BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

N/A

N/A

Net Income

N/A

N/A

EBITDA

N/A

N/A

Quarterly Fundamentals

Name
CurrentYOY CHG

Total Cash

N/A

N/A

Total Debt

N/A

N/A

Accounts Receivable

N/A

N/A

Inventory

N/A

N/A

Long Term Debt

N/A

N/A

Short Term Debt

N/A

N/A

Return on Assets

N/A

N/A

Return on Invested Capital

N/A

N/A

Free Cash Flow

N/A

N/A

Operating Cash Flow

N/A

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,684.24-0.00%
^DJIDJI
$53,254.61-0.01%
^IXICNASDAQ
$26,319.55-0.00%
BTCBitcoin
$78,890.00-0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
PCGPG&E
$13.27-0.20%
NVDANvidia
$220.78+0.01%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.97+0.11%
CNHCNH Industrial
$11.83+0.01%

Questions About AFX

What is the current price of Carl Zeiss Meditec Ag?

Carl Zeiss Meditec Ag is trading at €32.12 per share.

What is the 52-week range for Carl Zeiss Meditec Ag?

Over the past 52 weeks, Carl Zeiss Meditec Ag has traded between €22.68 and €48.08.

How much debt does Carl Zeiss Meditec Ag have?

As of the most recent reporting period, Carl Zeiss Meditec Ag reported total debt of €607.37M.

How much cash does Carl Zeiss Meditec Ag have on hand?

Carl Zeiss Meditec Ag reported €27.27M in cash and cash equivalents in its most recent financial results.

What is Carl Zeiss Meditec Ag’s dividend yield?

Carl Zeiss Meditec Ag currently has a dividend yield of 1.72%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services